6,678 trials
Adverse Effects
Primary: Pharmacokinetic Parameters Based on Plasma Concentration of Lidocaine and MEGX in Nanograms/Milliliter. — NA; NA nanograms/mililiter — p=<0.05
Postoperative Pain
Primary: Procedural Time — 577; 206 seconds
Panic Disorder
Primary: Panic Disorder Severity Scale (PDSS) — 9.13 units on a scale
Patient Comfort and Safety
Primary: Frequency of Subjects With Moderate/Severe Discomfort When Undergoing Contrast-Enhanced Computed Tomographic (CECT) Imaging of the Abdomen/Pelvis. — 53; 99 Number of…
Alzheimer Disease
Primary: Changes in the Metabolite Ratios of N-acetylaspartate (NAA) to Creatine (Cr), Myo-inositol (mI) to Cr, Choline (Cho) to Cr, NAA to Cho, and NAA to mI, on Cholinesterase…
Diabetes Mellitus, Type 2
Primary: Change in Haemoglobin A1c (HbA1c) From Baseline to 24 Week Endpoint — -1.05; -1.06 percent HbA1c
Non-small Cell Lung Cancer
Primary: Febrile Neutropenia — 12 participants
Allergic Rhinitis
Primary: Total Nasal Congestion Symptom Score — 94; 70; 75; 68 units on a scale
Hepatitis A
Primary: Seroprotection at Month 1 — 95.9; 96.6 percentage of participants
Heart Rate and Rhythm Disorders
Primary: Percent of Patients Reaching Target HR<100bpm Within 30 Minutes — 46.4; 95.8 percentage of participants — p=.0001
Open-Angle Glaucoma · Ocular Hypertension
Primary: Preferred Treatment — 60.2; 39.8 Percentage of participants
Chronic Hepatitis C
Primary: Sustained Virologic Response (SVR)Rate — 130; 72 participants — p=< 0.001
Cataract
Primary: Mean LogMAR Binocular Photopic Distance Corrected Near Visual Acuity at 33 cm — 0.07; 0.61 logMAR visual acuity
Diabetes
Primary: Objective: Comparisons of the Effects of Co-administration of Sitagliptin and Metformin Alone or in Combination Versus Placebo on Baseline Endogenous Glucose Production…
Atopic Dermatitis
Primary: Change From Baseline in Three Item Severity Score — -2.6; -3.6 units on a scale